Publication Name	World Journal of Gastroenterology
Manuscript ID	18794
Country	China

Received	2015-04-28 18:06
Peer-Review Started	2015-05-04 12:52
To Make the First Decision	2015-07-20 13:59
Return for Revision	2015-07-28 11:24
Revised	2015-08-22 23:46
Second Decision	2015-09-23 19:47
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-09-30 08:33
Articles in Press	2015-09-30 08:33
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-10-22 10:53
Publish the Manuscript Online	2015-11-11 13:34

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Topic Highlights
Article Title	Application of nucleoside analogues to liver transplant recipients with hepatitis B
Manuscript Source	Invited Manuscript
All Author List	Zhuo-Lun Song, Yu-Jun Cui, Wei-Ping Zheng, Da-Hong Teng and Hong Zheng
Funding Agency and Grant Number	Funding Agency Grant Number National High-tech R&D Program of China (863 Program) 2012AA021001
Corresponding Author	Hong Zheng, MD, PhD, Professor, Organ Transplantation Center, Tianjin Key Laboratory of Organ Transplantation, Tianjin First Center Hospital, 24 Fukang Road, Nankai District, Tianjin 300192, China. zhenghongxy@163.com
Key Words	Nucleoside analogues; Liver transplantation; Hepatitis B virus; Hepatitis B immunoglobulin; Hepatitis B core antibody positive donors; de novo hepatitis B; Prophylactic regimen
Core Tip	Hepatitis B virus (HBV)-related end-stage liver disease is a common indication for liver transplant. This review discusses application of nucleoside analogues (NAs) for patients on liver transplant waiting lists, as well as the preventive and therapeutic strategies of NAs for HBV recurrence post-transplantation. The prophylactic role of NAs for recipients of livers from HBV core antibody-positive donors is also discussed. This review will help physicians and surgeons improve management of HBV-related liver transplant patients.
Publish Date	2015-11-11 13:34
Citation	Song ZL, Cui YJ, Zheng WP, Teng DH, Zheng H. Application of nucleoside analogues to liver transplant recipients with hepatitis B. World J Gastroenterol 2015; 21(42): 12091-12100
URL	http://www.wjgnet.com/1007-9327/full/v21/i42/12091.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i42.12091

Full Article (PDF)	WJG-21-12091.pdf
Full Article (Word)	WJG-21-12091.doc
Manuscript File	18794-Review.docx
Answering Reviewers	18794-Answering reviewers.pdf
Audio Core Tip	18794-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	18794-Conflict-of-interest statement.pdf
Copyright License Agreement	18794-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	18794-Language certificate.pdf
Peer-review Report	18794-Peer-review(s).pdf
Scientific Misconduct Check	18794-Scientific misconduct check.pdf
Scientific Editor Work List	18794-Scientific editor work list.pdf